observed in hepatocellular carcinoma and BC that although applying Aspartate β‐hydroxylase‐targeted λ phage vaccine alone activates CXCL13/CXCR5 axis, it promotes an aggressive tumor phenotype and mediates effector T cell. Here, CXCL13 is linked to neoplasm.